OPTIMUM Trademark

Trademark Overview


On Monday, March 1, 2004, a trademark application was filed for OPTIMUM with the United States Patent and Trademark Office. The USPTO has given the OPTIMUM trademark a serial number of 78376424. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 5, 2012. This trademark is owned by Ambion, Inc.. The OPTIMUM trademark is filed in the Pharmaceutical Products category with the following description:

chemical reagents and chemical buffers for use in the isolation and purification of nucleic acids derived from organic material other than plant or seed tissue, performed in conjunction with the amplification and microarray analysis of nucleic acids for medical and clinical diagnostic testing applications; and kits compromised of chemical reagents and chemical buffers for use in the isolation and purification of nucleic acids derived from organic material other than plant or seed tissue, performed in conjunction with the amplification and microarray analysis of nucleic acids for medical and clinical diagnostic testing applications
optimum

General Information


Serial Number78376424
Word MarkOPTIMUM
Filing DateMonday, March 1, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 5, 2012
Registration Number3013052
Registration DateTuesday, November 8, 2005
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2005

Trademark Statements


Goods and Serviceschemical reagents and chemical buffers for use in the isolation and purification of nucleic acids derived from organic material other than plant or seed tissue, performed in conjunction with the amplification and microarray analysis of nucleic acids for medical and clinical diagnostic testing applications; and kits compromised of chemical reagents and chemical buffers for use in the isolation and purification of nucleic acids derived from organic material other than plant or seed tissue, performed in conjunction with the amplification and microarray analysis of nucleic acids for medical and clinical diagnostic testing applications

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 5, 2012
Primary Code005
First Use Anywhere DateFriday, December 12, 2003
First Use In Commerce DateFriday, December 12, 2003

Trademark Owner History


Party NameASURAGEN, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressAUSTIN, TX 78744

Party NameAmbion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAustin, TX 78744

Party NameAmbion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78744

Party NameAmbion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78744

Trademark Events


Event DateEvent Description
Friday, October 5, 2012CANCELLED SEC. 8 (6-YR)
Wednesday, April 11, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 8, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, August 16, 2005PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2005NOTICE OF PUBLICATION
Monday, April 25, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 22, 2005ASSIGNED TO LIE
Thursday, April 21, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, April 11, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 11, 2005FAX RECEIVED
Monday, April 4, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, March 14, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 14, 2005PAPER RECEIVED
Tuesday, September 21, 2004NON-FINAL ACTION E-MAILED
Tuesday, September 21, 2004NON-FINAL ACTION WRITTEN
Friday, September 17, 2004ASSIGNED TO EXAMINER
Wednesday, March 17, 2004NEW APPLICATION ENTERED IN TRAM